878
Views
20
CrossRef citations to date
0
Altmetric
Research Paper

CpG dinucleotide-specific hypermethylation of the TNS3 gene promoter in human renal cell carcinoma

, , , &
Pages 739-747 | Received 23 Jan 2013, Accepted 17 May 2013, Published online: 24 May 2013

References

  • Lo SH. Tensin. Int J Biochem Cell Biol 2004; 36:31 - 4; http://dx.doi.org/10.1016/S1357-2725(03)00171-7; PMID: 14592531
  • Hafizi S, Ibraimi F, Dahlbäck B. C1-TEN is a negative regulator of the Akt/PKB signal transduction pathway and inhibits cell survival, proliferation, and migration. FASEB J 2005; 19:971 - 3; PMID: 15817639
  • Chuang JZ, Lin DC, Lin S. Molecular cloning, expression, and mapping of the high affinity actin-capping domain of chicken cardiac tensin. J Cell Biol 1995; 128:1095 - 109; http://dx.doi.org/10.1083/jcb.128.6.1095; PMID: 7896874
  • Lo SH, Janmey PA, Hartwig JH, Chen LB. Interactions of tensin with actin and identification of its three distinct actin-binding domains. J Cell Biol 1994; 125:1067 - 75; http://dx.doi.org/10.1083/jcb.125.5.1067; PMID: 8195290
  • Calderwood DA, Fujioka Y, de Pereda JM, García-Alvarez B, Nakamoto T, Margolis B, et al. Integrin beta cytoplasmic domain interactions with phosphotyrosine-binding domains: a structural prototype for diversity in integrin signaling. Proc Natl Acad Sci U S A 2003; 100:2272 - 7; http://dx.doi.org/10.1073/pnas.262791999; PMID: 12606711
  • Hafizi S, Alindri F, Karlsson R, Dahlbäck B. Interaction of Axl receptor tyrosine kinase with C1-TEN, a novel C1 domain-containing protein with homology to tensin. Biochem Biophys Res Commun 2002; 299:793 - 800; http://dx.doi.org/10.1016/S0006-291X(02)02718-3; PMID: 12470648
  • Chan LK, Ko FC, Ng IO, Yam JW. Deleted in liver cancer 1 (DLC1) utilizes a novel binding site for Tensin2 PTB domain interaction and is required for tumor-suppressive function. PLoS One 2009; 4:e5572; http://dx.doi.org/10.1371/journal.pone.0005572; PMID: 19440389
  • Katz M, Amit I, Citri A, Shay T, Carvalho S, Lavi S, et al. A reciprocal tensin-3-cten switch mediates EGF-driven mammary cell migration. Nat Cell Biol 2007; 9:961 - 9; http://dx.doi.org/10.1038/ncb1622; PMID: 17643115
  • Hafizi S, Sernstad E, Swinny JD, Gomez MF, Dahlbäck B. Individual domains of Tensin2 exhibit distinct subcellular localisations and migratory effects. Int J Biochem Cell Biol 2010; 42:52 - 61; http://dx.doi.org/10.1016/j.biocel.2009.09.005; PMID: 19747564
  • Martuszewska D, Ljungberg B, Johansson M, Landberg G, Oslakovic C, Dahlbäck B, et al. Tensin3 is a negative regulator of cell migration and all four Tensin family members are downregulated in human kidney cancer. PLoS One 2009; 4:e4350; http://dx.doi.org/10.1371/journal.pone.0004350; PMID: 19194507
  • Nishino T, Sasaki N, Chihara M, Nagasaki K, Torigoe D, Kon Y, et al. Distinct distribution of the tensin family in the mouse kidney and small intestine. Exp Anim 2012; 61:525 - 32; http://dx.doi.org/10.1538/expanim.61.525; PMID: 23095816
  • Lo SH, Yu QC, Degenstein L, Chen LB, Fuchs E. Progressive kidney degeneration in mice lacking tensin. J Cell Biol 1997; 136:1349 - 61; http://dx.doi.org/10.1083/jcb.136.6.1349; PMID: 9087448
  • Chiang MK, Liao YC, Kuwabara Y, Lo SH. Inactivation of tensin3 in mice results in growth retardation and postnatal lethality. Dev Biol 2005; 279:368 - 77; http://dx.doi.org/10.1016/j.ydbio.2004.12.027; PMID: 15733665
  • The American Cancer Society. What are the key statistics about kidney cancer. In: The American Cancer Society, ed. Kidney Cancer (Adult) - Renal Cell Carcinoma. Atlanta, GA: The American Cancer Society, 2012.
  • Schmidt L, Junker K, Nakaigawa N, Kinjerski T, Weirich G, Miller M, et al. Novel mutations of the MET proto-oncogene in papillary renal carcinomas. Oncogene 1999; 18:2343 - 50; http://dx.doi.org/10.1038/sj.onc.1202547; PMID: 10327054
  • Morris MR, Maher ER. Epigenetics of renal cell carcinoma: the path towards new diagnostics and therapeutics. Genome Med 2010; 2:59; http://dx.doi.org/10.1186/gm180; PMID: 20815920
  • Larsen F, Gundersen G, Lopez R, Prydz H. CpG islands as gene markers in the human genome. Genomics 1992; 13:1095 - 107; http://dx.doi.org/10.1016/0888-7543(92)90024-M; PMID: 1505946
  • Saxonov S, Berg P, Brutlag DL. A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters. Proc Natl Acad Sci U S A 2006; 103:1412 - 7; http://dx.doi.org/10.1073/pnas.0510310103; PMID: 16432200
  • Christoph F, Weikert S, Kempkensteffen C, Krause H, Schostak M, Köllermann J, et al. Promoter hypermethylation profile of kidney cancer with new proapoptotic p53 target genes and clinical implications. Clin Cancer Res 2006; 12:5040 - 6; http://dx.doi.org/10.1158/1078-0432.CCR-06-0144; PMID: 16951219
  • Esteller M, Fraga MF, Guo M, Garcia-Foncillas J, Hedenfalk I, Godwin AK, et al. DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis. Hum Mol Genet 2001; 10:3001 - 7; http://dx.doi.org/10.1093/hmg/10.26.3001; PMID: 11751682
  • Moore LE, Nickerson ML, Brennan P, Toro JR, Jaeger E, Rinsky J, et al. Von Hippel-Lindau (VHL) inactivation in sporadic clear cell renal cancer: associations with germline VHL polymorphisms and etiologic risk factors. PLoS Genet 2011; 7:e1002312; http://dx.doi.org/10.1371/journal.pgen.1002312; PMID: 22022277
  • Ibanez de Caceres I, Dulaimi E, Hoffman AM, Al-Saleem T, Uzzo RG, Cairns P. Identification of novel target genes by an epigenetic reactivation screen of renal cancer. Cancer Res 2006; 66:5021 - 8; http://dx.doi.org/10.1158/0008-5472.CAN-05-3365; PMID: 16707423
  • Rice P, Longden I, Bleasby A. EMBOSS: the European Molecular Biology Open Software Suite. Trends Genet 2000; 16:276 - 7; http://dx.doi.org/10.1016/S0168-9525(00)02024-2; PMID: 10827456
  • Gardiner-Garden M, Frommer M. CpG islands in vertebrate genomes. J Mol Biol 1987; 196:261 - 82; http://dx.doi.org/10.1016/0022-2836(87)90689-9; PMID: 3656447
  • Li L-C, Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinformatics 2002; 18:1427 - 31; http://dx.doi.org/10.1093/bioinformatics/18.11.1427; PMID: 12424112
  • Ryschich E, Lizdenis P, Ittrich C, Benner A, Stahl S, Hamann A, et al. Molecular fingerprinting and autocrine growth regulation of endothelial cells in a murine model of hepatocellular carcinoma. Cancer Res 2006; 66:198 - 211; http://dx.doi.org/10.1158/0008-5472.CAN-05-1636; PMID: 16397233
  • Santin AD, Zhan F, Cane’ S, Bellone S, Palmieri M, Thomas M, et al. Gene expression fingerprint of uterine serous papillary carcinoma: identification of novel molecular markers for uterine serous cancer diagnosis and therapy. Br J Cancer 2005; 92:1561 - 73; http://dx.doi.org/10.1038/sj.bjc.6602480; PMID: 15785748
  • Dahl E, Sadr-Nabavi A, Klopocki E, Betz B, Grube S, Kreutzfeld R, et al. Systematic identification and molecular characterization of genes differentially expressed in breast and ovarian cancer. J Pathol 2005; 205:21 - 8; http://dx.doi.org/10.1002/path.1687; PMID: 15586368
  • Kim KE, Song H, Kim TS, Yoon D, Kim CW, Bang SI, et al. Interleukin-18 is a critical factor for vascular endothelial growth factor-enhanced migration in human gastric cancer cell lines. Oncogene 2007; 26:1468 - 76; http://dx.doi.org/10.1038/sj.onc.1209926; PMID: 17001321
  • Albasri A, Seth R, Jackson D, Benhasouna A, Crook S, Nateri AS, et al. C-terminal Tensin-like (CTEN) is an oncogene which alters cell motility possibly through repression of E-cadherin in colorectal cancer. J Pathol 2009; 218:57 - 65; http://dx.doi.org/10.1002/path.2508; PMID: 19214987
  • Sasaki H, Yukiue H, Kobayashi Y, Fukai I, Fujii Y. Cten mRNA expression is correlated with tumor progression in thymoma. Tumour Biol 2003; 24:271 - 4; http://dx.doi.org/10.1159/000076141; PMID: 15001839
  • Lo SH, Lo TB. Cten, a COOH-terminal tensin-like protein with prostate restricted expression, is down-regulated in prostate cancer. Cancer Res 2002; 62:4217 - 21; PMID: 12154022
  • Albasri A, Aleskandarany M, Benhasouna A, Powe DG, Ellis IO, Ilyas M, et al. CTEN (C-terminal tensin-like), a novel oncogene overexpressed in invasive breast carcinoma of poor prognosis. Breast Cancer Res Treat 2011; 126:47 - 54; http://dx.doi.org/10.1007/s10549-010-0890-3; PMID: 20390342
  • Li Y, Mizokami A, Izumi K, Narimoto K, Shima T, Zhang J, et al. CTEN/tensin 4 expression induces sensitivity to paclitaxel in prostate cancer. Prostate 2010; 70:48 - 60; http://dx.doi.org/10.1002/pros.21037; PMID: 19725034
  • Liao YC, Chen NT, Shih YP, Dong Y, Lo SH. Up-regulation of C-terminal tensin-like molecule promotes the tumorigenicity of colon cancer through beta-catenin. Cancer Res 2009; 69:4563 - 6; http://dx.doi.org/10.1158/0008-5472.CAN-09-0117; PMID: 19487278
  • Sasaki H, Moriyama S, Mizuno K, Yukiue H, Konishi A, Yano M, et al. Cten mRNA expression was correlated with tumor progression in lung cancers. Lung Cancer 2003; 40:151 - 5; http://dx.doi.org/10.1016/S0169-5002(03)00037-0; PMID: 12711115
  • The EPC, ENCODE Project Consortium. A user’s guide to the encyclopedia of DNA elements (ENCODE). PLoS Biol 2011; 9:e1001046; http://dx.doi.org/10.1371/journal.pbio.1001046; PMID: 21526222
  • Biel M, Wascholowski V, Giannis A. Epigenetics--an epicenter of gene regulation: histones and histone-modifying enzymes. Angew Chem Int Ed Engl 2005; 44:3186 - 216; http://dx.doi.org/10.1002/anie.200461346; PMID: 15898057
  • Li B, Carey M, Workman JL. The role of chromatin during transcription. Cell 2007; 128:707 - 19; http://dx.doi.org/10.1016/j.cell.2007.01.015; PMID: 17320508
  • Kim TH, Abdullaev ZK, Smith AD, Ching KA, Loukinov DI, Green RD, et al. Analysis of the vertebrate insulator protein CTCF-binding sites in the human genome. Cell 2007; 128:1231 - 45; http://dx.doi.org/10.1016/j.cell.2006.12.048; PMID: 17382889
  • Yang J, Corces VG. Insulators, long-range interactions, and genome function. Curr Opin Genet Dev 2012; 22:86 - 92; http://dx.doi.org/10.1016/j.gde.2011.12.007; PMID: 22265227
  • Bell LA, Ryan KM. Life and death decisions by E2F-1. Cell Death Differ 2004; 11:137 - 42; http://dx.doi.org/10.1038/sj.cdd.4401324; PMID: 14526389
  • Zhang Q, Stovall DB, Inoue K, Sui G. The oncogenic role of Yin Yang 1. Crit Rev Oncog 2011; 16:163 - 97; http://dx.doi.org/10.1615/CritRevOncog.v16.i3-4.30; PMID: 22248053
  • Abdulrazzak H, Noro N, Simons JP, Goldspink G, Barnard EA, Górecki DC. Structural diversity despite strong evolutionary conservation in the 5′-untranslated region of the P-type dystrophin transcript. Mol Cell Neurosci 2001; 17:500 - 13; http://dx.doi.org/10.1006/mcne.2000.0950; PMID: 11273645
  • Christman JK. 5-Azacytidine and 5-aza-2′-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy. Oncogene 2002; 21:5483 - 95; http://dx.doi.org/10.1038/sj.onc.1205699; PMID: 12154409
  • Ryan MJ, Johnson G, Kirk J, Fuerstenberg SM, Zager RA, Torok-Storb B. HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney. Kidney Int 1994; 45:48 - 57; http://dx.doi.org/10.1038/ki.1994.6; PMID: 8127021
  • Maherally Z, Smith JR, An Q, Pilkington GJ. Receptors for hyaluronic acid and poliovirus: a combinatorial role in glioma invasion?. PLoS One 2012; 7:e30691; http://dx.doi.org/10.1371/journal.pone.0030691; PMID: 22363471

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.